[Neurohormonal compensation processes in chronic heart failure: the effect of drugs].
van Zwieten
P A
PA
Academisch Medisch Centrum, afd. Farmacotherapie en Cardiologie, Amsterdam.
Lie
K I
KI
D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D002301:Cardiac Glycosides / Q000494:pharmacology; D002316:Cardiotonic Agents / Q000494:pharmacology; D003846:Deoxyepinephrine / Q000031:analogs & derivatives / Q000494:pharmacology; D004232:Diuretics / Q000494:pharmacology; D004280:Dobutamine / Q000494:pharmacology; D006333:Heart Failure / Q000503:physiopathology*; D006801:Humans; D011956:Receptors, Cell Surface / Q000502:physiology; D012084:Renin-Angiotensin System / Q000502:physiology*; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000503:physiopathology*
D000318:Adrenergic beta-Agonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002301:Cardiac Glycosides; D002316:Cardiotonic Agents; D004232:Diuretics; D011956:Receptors, Cell Surface; D000804:Angiotensin II; D004280:Dobutamine; C023487:ibopamine; D003846:Deoxyepinephrine
Neurohormonale compensatieprocessen bij chronische decompensatio cordis; de invloed van geneesmiddelen.